03.02.21 -- FDA's COVID-19 PREPP Initiative Summary Report -- Keys For Manufacturers
03.02.21 -- FDAs COVID-19 PREPP Initiative Summary Report -- Keys For Manufacturers This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CMO service quality across a series of 22 performance attributes specific to outsourced drug substance manufacturing. ISR presents data on 358 service encounters from 123 respondents who hav...
Source: pharmaceuticalonline.com